Jiaan-der H. Wang

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Association of the PROC rs146922325 variant with venous thrombosis in a Taiwanese population.

Association of the PROC rs146922325 variant with venous thrombosis in a Taiwanese population.

Journal: Blood research

Published: April 21, 2026

Successful Perioperative Management of the Bentall Procedure in a Patient With Severe Hemophilia A, Infective Endocarditis, and Advanced Valve Disease.

Successful Perioperative Management of the Bentall Procedure in a Patient With Severe Hemophilia A, Infective Endocarditis, and Advanced Valve Disease.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 14, 2026

Indoxyl sulfate promoted glutamine metabolism and cell proliferation in urothelial carcinoma involving Runx2.

Indoxyl sulfate promoted glutamine metabolism and cell proliferation in urothelial carcinoma involving Runx2.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 10, 2025

NXTAGE: a phase 1/2 study of NXT007 to assess safety, pharmacokinetics, and efficacy in hemophilia A without inhibitors.

NXTAGE: a phase 1/2 study of NXT007 to assess safety, pharmacokinetics, and efficacy in hemophilia A without inhibitors.

Journal: Blood

Published: September 30, 2025

Impact of Fidanacogene Elaparvovec Gene Therapy on Joint Health in Adults With Haemophilia B: Results From a Phase 3 Study.

Impact of Fidanacogene Elaparvovec Gene Therapy on Joint Health in Adults With Haemophilia B: Results From a Phase 3 Study.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: June 13, 2025

Epidemiological characteristics and natural history of porphyria - a twenty-year population-based analysis in Taiwan.

Epidemiological characteristics and natural history of porphyria - a twenty-year population-based analysis in Taiwan.

Journal: Orphanet journal of rare diseases

Published: May 05, 2025

Claw hands in acute intermittent porphyria.

Claw hands in acute intermittent porphyria.

Journal: Oxford medical case reports

Published: April 30, 2025

Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: results from the BENEGENE-2 trial.

Health-related quality of life in adults with hemophilia B after gene therapy with fidanacogene elaparvovec: results from the BENEGENE-2 trial.

Journal: Journal of thrombosis and haemostasis : JTH

Published: April 17, 2025

Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.

Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.

Journal: The New England journal of medicine

Published: September 25, 2024

Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study.

Evaluating the Effectiveness of Prophylactic Strategies for Hemophilia A Management: A Real-World, Longitudinal Observational Study.

Journal: Drugs - real world outcomes

Published: August 25, 2024

Runx2 silencing sensitized human renal cell carcinoma cells to ABT-737 apoptosis.

Runx2 silencing sensitized human renal cell carcinoma cells to ABT-737 apoptosis.

Journal: Archives of biochemistry and biophysics

Published: June 26, 2024

Outcomes and management of invasive procedures in participants with hemophilia A post gene therapy: a post hoc analysis of the GENEr8-1 phase III trial.

Outcomes and management of invasive procedures in participants with hemophilia A post gene therapy: a post hoc analysis of the GENEr8-1 phase III trial.

Journal: Therapeutic advances in hematology

Published: May 10, 2024

Showing 1-12 of 75

Last Updated: 09/26/2026